What is NDC 0093-3061?

0093-3061 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rasagiline?

26 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rasagiline NDC 0093-3061 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-3061Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-3061Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-3061-56	0009330615600093306156	30 TABLET in 1 BOTTLE (0093-3061-56)Marketed from Jan 3, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasagiline
Generic name (nonproprietary): rasagiline
Active ingredients: Rasagiline mesylate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 021641
Marketing start: Jan 3, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Monoamine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 0093-3061_dc5c47b7-316b-4342-878b-d0dcbe0387f0SPL ID dc5c47b7-316b-4342-878b-d0dcbe0387f0SPL set ID e802c83c-e581-4a11-b83d-1df47120078dRxCUI 608328, 636664UNII LH8C2JI290
Pharmacologic class: Monoamine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093306156 followed by a unit qualifier and the quantity

Package 00093-3061-56. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2020.

Indications (excerpt from the label)

Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson’s disease

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-3061

What is NDC 0093-3061?: 0093-3061 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rasagiline.
What is the active ingredient?: Rasagiline mesylate.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rasagiline?: 26 other product NDCs are listed under this name. See all Rasagiline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rasagiline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rasagiline	Rasagiline mesylate 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4735	70518-4735-0070518-4735-01
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4683	70518-4683-00
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-141	80005-0141-0880005-0141-1080005-0141-14
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-142	80005-0142-0880005-0142-1080005-0142-14
Rasagiline	Rasagiline mesylate 1 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-446	13668-0446-0513668-0446-3013668-0446-90
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-447	13668-0447-0513668-0447-3013668-0447-90
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-711	64980-0711-30
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-712	64980-0712-30
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	SKG Pharma Inc.	83085-007	83085-0007-1083085-0007-3083085-0007-50
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	SKG Pharma Inc.	83085-008	83085-0008-1083085-0008-3083085-0008-50

All 27 Rasagiline NDCs

Other NDCs under NDA 021641

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021641
Product	Strength	Form · route	Labeler	Product NDC
Azilectrasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Teva Neuroscience, Inc.	68546-142
Azilectrasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Teva Neuroscience, Inc.	68546-229
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-3060